(Q33328389)

25 July 2017

title

Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patients (English)

1 reference

25 July 2017

0 references

Pneumocystis carinii

1 reference

Nicolau DP

1

1 reference

25 July 2017

Ross JW

series ordinal

2

1 reference

25 July 2017

Quintiliani R

series ordinal

3

1 reference

25 July 2017

Nightingale CH

series ordinal

4

1 reference

25 July 2017

language of work or name

1 reference

1 July 1996

1 reference

25 July 2017

1 reference

25 July 2017

volume

10

1 reference

25 July 2017

issue

1

1 reference

25 July 2017

page(s)

72-78

1 reference

The rising cost of pharmaceuticals: a hospital executive's perspective

25 July 2017

cites work

1 reference

12 December 2020

A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

The costs of burn care: an analysis with an emphasis on the use of parenteral antimicrobials.

1 reference

12 December 2020

A Controlled Study of Inhaled Pentamidine for Primary Prevention ofPneumocystis cariniiPneumonia

1 reference

12 December 2020

The pharmacoeconomics of HIV disease

1 reference

12 December 2020

Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS

1 reference

12 December 2020

Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure

1 reference

12 December 2020

Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends.

1 reference

12 December 2020

Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group

1 reference

12 December 2020

Projecting the medical costs of AIDS and ARC in the United States.

1 reference

12 December 2020

Pneumocystis carinii, an opportunist in immunocompromised patients

1 reference

12 December 2020

Forecasts of the costs of medical care for persons with HIV: 1992-1995.

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

1 reference

12 December 2020

Assessment of therapy for pneumocystis carinii pneumonia. PCP Therapy Project Group

1 reference

12 December 2020

Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop

1 reference

12 December 2020

Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex.

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

1 reference

12 December 2020

10.2165/00019053-199610010-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1032830820

0 references

1 reference